India’s Biocon Creates Mideast JV; Partners to Build Biotech Plant

Biocon Ltd. (Bangalore), one of India’s leading biotechnology firms, and pharmaceutical manufacturer Neopharma (Abu Dhabi) say they have entered into a joint venture agreement to manufacture and market a range of biopharmaceuticals in the Gulf Cooperation Council (GCC) countries. The jv will provide Neopharma with an entry into the market for biotech drugs, and give Biocon access to markets in the Mideast. The partners plan to build the Mideast’s first facility for developing and producing biotech and biopharma products, they say. The location of the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers